Literature DB >> 3104483

Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.

S C Aronoff, D M Shlaes.   

Abstract

Induction ratios were determined for beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa by using 10 beta-lactam agents. For E. cloacae, pre-incubation with ceftriaxone, cefoxitin, cefamandole, cefoperazone, or imipenem produced significantly larger amounts of beta-lactamase than did pre-incubation with moxalactam, clavulanate, ceftazidime, or aztreonam. For P. aeruginosa, imipenem was the best inducer, whereas ceftriaxone, piperacillin, cefoperazone, cefamandole, clavulanate, and aztreonam were poor beta-lactamase inducers. The rate of emergence of resistance by E. cloacae p99 and P. aeruginosa ATCC 27853 did not correlate with the induction ratio of the selecting agent; however, a strong correlation was noted between the mutation rate and the ratio of the MIC to the concentration of selecting antibiotic used. Emergence of resistance is related to the MIC of the antibiotic and the concentration of antibiotic used to select for resistance and is independent of the efficacy of the beta-lactam inducer. Resistant mutants arise through both beta-lactamase-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104483     DOI: 10.1093/infdis/155.5.936

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins.

Authors:  D Kalman; S L Barriere
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Resistance to third generation cephalosporins: the current situation.

Authors:  J C Pechère
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

3.  In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.

Authors:  M D Kitzis; B Ferré; A Coutrot; J F Acar; L Gutmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

Review 4.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

5.  Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert; Y Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

6.  Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit.

Authors:  P R Hsueh; L J Teng; P C Yang; Y C Chen; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.

Authors:  J C Pechère
Journal:  Drugs       Date:  1988       Impact factor: 9.546

8.  Distribution and antibiotic susceptibility of extraintestinal clinical isolates of Klebsiella, Enterobacter and Serratia species.

Authors:  P E Varaldo; F Biavasco; S Mannelli; R Pompei; A Proietti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

9.  In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.

Authors:  K Nishida; C Kunugita; T Uji; F Higashitani; A Hyodo; N Unemi; S N Maiti; O A Phillips; P Spevak; K P Atchison; S M Salama; H Atwal; R G Micetich
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

10.  Production and induction of beta-lactamase during growth of Pseudomonas aeruginosa in biological fluids.

Authors:  E D Letendre; P L Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.